Teqnion AB (TEQ)
Stockholm Exchange · Sweden · prices in SEK · close of 23 Oct 2026
Key indicators
| Last close | SEK 177.20 |
|---|---|
| 52-week range | 136.60 – 191.80 |
| Return, 1 month / 3 months | −3.7% / +9.4% |
| Return, 1 year / 3 years | +0.0% / −15.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 45 |
| Volatility (1 year) | 29.5% |
| Worst drawdown (1 year) | -25.3% |
| Average daily value traded | 3.31M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Teqnion AB is a Swedish industrial group based in Sweden that acquires and develops smaller niche businesses. Its subsidiaries make and sell industrial products and technical equipment, including components, tools and specialised machinery, serving business customers in manufacturing and related trades. The group runs a decentralised model in which the acquired companies keep their own management and continue to serve their own markets, while the parent company supports them with capital and long-term ownership.
The shares are listed on the Stockholm Exchange in Sweden under the code TEQ, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Teqnion AB (TEQ) trades on the Stockholm Exchange in Sweden. It last closed at SEK 177.20 on 23 October 2026.
Its price-based Market X-Ray is 77 out of 100 (a strong price profile), ranking 95 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.0% and over the last three months it rose 9.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 82 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 6.7% | ||
| From 52-week high | -5.5% | ||
| Momentum | 73 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 9.4% | ||
| 6-month return | 10.2% | ||
| 12-month return, skipping the last month | 3.8% | ||
| Stability (higher is calmer) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 29.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.3% | ||
| Liquidity | 71 · Strong | Trades actively. | |
| Average daily value traded | 3.31M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.6% |
|---|---|
| 1 month | −3.7% |
| 3 months | +9.4% |
| 6 months | +10.2% |
| 1 year | +0.0% |
| 3 years | −15.0% |
| 5 years | +55.5% |
Signals
| 50-day / 200-day average | 181.88 / 166.01 |
|---|---|
| Golden / death cross (60 days) | Golden, 50 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.70 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 May 2022 | SEK 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.